HOME Research Insight Product Development and Commercialization was the Key Strategy Adopted by Leading Market Players to Foster their Growth in the Global Transplant Diagnostics Market



Product Development and Commercialization was the Key Strategy Adopted by Leading Market Players to Foster their Growth in the Global Transplant Diagnostics Market


The key players in the transplant diagnostics market focus on various strategies such as product launches and commercialization; agreements, partnerships and collaborations; acquisitions; and expansions in order to enhance their presence in the global market. These strategies were majorly adopted by Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Immucor, Inc. (U.S), bioMérieux (France), and Becton, Dickinson and Company (U.S.). The key strategy adopted by major industry players to achieve growth in the transplant diagnostics market is product development and commercialization. This strategy accounted for the largest share of the overall growth strategies adopted by key market players from 2013 to 2016. The increasing market demand for transplant diagnostic instruments and reagents, growing preference for genomics-based diagnosis for donor-recipient compatibility during a transplantation, and growing awareness on and adoption of personalized treatments, including gene-based diagnostics, are some key factors encouraging market players to adopt this strategy.

In 2015, Thermo Fisher Scientific, Inc. (U.S.) held the leading position in the transplant diagnostics market owing to its robust product portfolio and its strong geographic presence across major markets (such as the U.S., China, Germany, and the U.K). The company primarily focuses on development and commercialization of transplant diagnostic products as its key growth strategy. The company launched transplant diagnostic products including Thermo Scientific TSX Series refrigerators, Thermo Scientific TSX Series plasma freezers, Thermo Scientific Sorvall BP 8, and 16 blood banking centrifuges & Thermo Scientific Medifuge benchtop centrifuge (October 2016), LABScreen Multi screening kit (April 2015), and RUO NXType kit (December 2014). Furthermore, the company acquired Affymetrix Inc. (U.S.) (March 2016) & Life Technologies Corporation (U.S.) (February 2014) in order to strengthen their R&D capabilities and distribution networks in the market.

Bio-Rad Laboratories, Inc. (U.S.) held the second position in the transplant diagnostics market in 2015. This is mainly attributed to its strong product portfolio which includes automated instruments for antibody screening and analysis, semi-automated systems for serological assays, standalone systems, and reagents for molecular and non-molecular assay procedures (including for transplant diagnostic screening). The company has primarily adopted product launches and commercialization as its key growth strategy to strengthen its position in the market. Pertaining to this fact, during 2013-2016, Bio-Rad Laboratories, Inc. developed and commercialized several transplant diagnostic products such as IH-500 (August 2015), BioPlex 2200 HIV Ag-Ab assay kit (July 2015), QX200 Droplet Digital PCR (ddPCR) system (July 2013), and ddPCR library quantification kit (April 2013). Moreover, Bio-Rad Laboratories is also concentrates on strengthening its R&D capabilities to assist in pipeline development of innovative transplant diagnostic products; that would help the company to expand its consumer base and offer its existing customers with novel products. For instance, in January 2016, Bio-Rad Laboratories, Inc. entered into a strategic partnership with Illumina, Inc. (U.S.) for the co-development of next-generation sequencing (NGS) workflow for single-cell analysis. Similarly, in April 2014, Bio-Rad Laboratories acquired GnuBIO, Inc. (U.S.) for USD 2.1 billion. GnuBIO, Inc. offers microfluidics-based DNA sequencing platform for various clinical applications

Related Reports:

Transplant Diagnostics Market by Technology (PCR, SSO-PCR, SSP-PCR, NGS, Sanger’s Sequencing, Microarray), Products & Services (Instruments, Reagents), Application (Blood Profiling, Infectious Disease Testing), End User (Hospitals) - Global forecast 2021

Contact:
Mr. Rohan
Markets and Markets 
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports